Paladin Advisory Group’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,387
| Closed | -$17K | – | 240 |
|
|
2024
Q3 | $17K | Hold |
4,387
| – | – | 0.01% | 190 |
|
|
2024
Q2 | $9.93K | Hold |
4,387
| – | – | 0.01% | 190 |
|
|
2024
Q1 | $12.5K | Hold |
4,387
| – | – | 0.01% | 187 |
|
|
2023
Q4 | $14K | Hold |
4,387
| – | – | 0.01% | 187 |
|
|
2023
Q3 | $14.5K | Hold |
4,387
| – | – | 0.01% | 201 |
|
|
2023
Q2 | $14.5K | Hold |
4,387
| – | – | 0.01% | 206 |
|
|
2023
Q1 | $14.5K | Buy |
+4,387
| New | +$14.5K | 0.01% | 204 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 277 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 283 |
|
|
2022
Q2 | – | Sell |
-4,382
| Closed | -$40K | – | 284 |
|
|
2022
Q1 | $40K | Buy |
+4,382
| New | +$40K | 0.03% | 187 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 276 |
|